DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
RAAV2.5-CMV-minidystrophin (d3990) ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
113
筋ジストロフィー
1
113. 筋ジストロフィー
臨床試験数
:
646
/
薬物数
:
471
- (
DrugBank
:
105
) /
標的遺伝子数
:
59
-
標的パスウェイ数
:
170
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00428935
(
ClinicalTrials.gov
)
March 2006
26/1/2007
Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
Phase 1 Clinical Trial of rAAV2.5-CMV-mini-Dystrophin Gene Vector in Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Biological:
rAAV2.5-CMV-minidystrophin (d3990)
Nationwide Children's Hospital
Asklepios Biopharmaceutical, Inc.
Completed
5 Years
15 Years
Male
6
Phase 1
United States